Recent discovery of tyrosinase inhibitors in traditional Chinese medicines and screening methods

被引:24
|
作者
Li, Jiaxu [1 ]
Li, Chenyue [1 ]
Peng, Xin [3 ]
Li, Shaoping [4 ]
Liu, Bingrui [2 ,6 ]
Chu, Chu [1 ,5 ]
机构
[1] Zhejiang Univ Technol, Sch Pharm, Hangzhou 310014, Peoples R China
[2] North China Univ Sci & Technol, Sch Publ Hlth, Tangshan 063210, Peoples R China
[3] Ningbo Res Inst Tradit Chinese Med, Ningbo 315100, Peoples R China
[4] Univ Macau, Inst Chinese Med Sci, Taipa 999078, Peoples R China
[5] Zhejiang Univ Technol, Hangzhou 310014, Zhejiang, Peoples R China
[6] North China Univ Sci & Technol, Tangshan 063210, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
Tyrosinase inhibitors; Traditional Chinese medicines; Screening methods; SURFACE-PLASMON RESONANCE; MUSHROOM TYROSINASE; CAPILLARY-ELECTROPHORESIS; PRENYLATED FLAVONOIDS; NATURAL TYROSINASE; QUANTUM DOTS; LIVING CELLS; CONSTITUENTS; MELANIN; GLYCOSIDES;
D O I
10.1016/j.jep.2022.115951
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Tyrosinase, the key rate-limiting enzyme for melanogenesis, is one of the main targets for skin senescence and some pigmented skin diseases, such as albinism and melanoma. Tyrosinase in-hibitors are capable of reducing melanin generation and deposition in the skin through blocking the reaction chain of formation. Thus, it has been used for anti-melanoma and showed the potential to be developed into novel skin whitening and spot removing products. With the trend of back-to-nature, natural tyrosinase inhibitors are receiving more and more attention. Traditional Chinese medicines (TCMs) as the promising source of novel chemotypes and pharmacophores, are huge treasures for the discovery of natural tyrosinase inhibitors charac-terized with green, safe, and highly efficient. Aim of this review: This review aims to provide a systematic overview of natural tyrosinase inhibitors and a detailed summary of the types of TCMs from which they originate. In addition, this paper also highlights the screening methods developed for exploring tyrosinase inhibitors in recent years, compares the advantages and disadvantages of various methods under the guidance of different screening principles, and predicts their ap-plications in the future. Materials and methods: Relevant literature have been obtained using the keywords "tyrosinase inhibitors", "traditional Chinese medicines", "whitening", and "screening" in scientific databases, such as "PubMed", "Sci-Finder", "Web of Science", "Elsevier", "China Knowledge Resource Integrated databases". Information was also collected from Chinese pharmacopoeia, Chinese herbal classics books, "Google Scholar", "Baidu Scholar", and other literature sources, etc. Results: An overview about the tyrosinase inhibitors derived from TCMs since 2002 has been compiled via the above-mentioned sources. Up to now, 186 components, mainly belonging to flavonoids, lignans, terpenoids, Diels-Alder adducts, simple phenylpropanoids and stilbenes, from 61 kinds of TCMs have been reported to possess tyrosinase inhibitory activity, among which flavonoids are mainly focused on. Furthermore, on the basis of bioactive detection strategies, the screening methods for tyrosinase inhibitors have been classified into bioaffinity-based, intrinsic enzymatic-based, and computer-aided drug design (CADD). Precisely because screening approaches are essential for rapid identification of tyrosinase inhibitors from TCMs, the principles, advantages and disadvantages, and specific applications of each method are presented along with a comparison of applicability. Conclusions: The summary of TCMs-derived inhibitors gives a clue on the discovery of candidates with the property to whiten the skin. Meanwhile, the outlook of developed screening methods provides technical refer-ences for the efficient exploration of safer and more effective tyrosinase inhibitors from TCMs.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Recent developments in sample preparation techniques for chromatography analysis of traditional Chinese medicines
    Deng, Chunhui
    Liu, Ning
    Gao, Mingxia
    Zhang, Xiangmin
    JOURNAL OF CHROMATOGRAPHY A, 2007, 1153 (1-2) : 90 - 96
  • [42] Screening for Neuraminidase Inhibitory Activity in Traditional Chinese Medicines Used to Treat Influenza
    Yang, Xian-Ying
    Liu, Ai-lin
    Liu, Shu-jing
    Xu, Xiao-wei
    Huang, Lin-Fang
    MOLECULES, 2016, 21 (09)
  • [43] Cathepsin B inhibitor screening in traditional Chinese medicines by electrophoretically mediated microanalysis
    Han, Jing
    Chen, Zilin
    Analytical Methods, 2016, 8 (48) : 8528 - 8533
  • [44] Developing a QSAR model for hepatotoxicity screening of the active compounds in traditional Chinese medicines
    Huang, Shan-Han
    Tung, Chun-Wei
    Fueloep, Ferenc
    Li, Jih-Heng
    FOOD AND CHEMICAL TOXICOLOGY, 2015, 78 : 71 - 77
  • [45] Screening of new non-nucleoside reverse transcriptase inhibitors of HIV-1 based on traditional Chinese medicines database
    Liu, Tao
    Li, Ai Xiu
    Miao, You Pan
    Wu, Ke Zhu
    Ma, Yi
    CHINESE CHEMICAL LETTERS, 2009, 20 (11) : 1386 - 1388
  • [46] Quality Control for Traditional Medicines–Chinese Patent Medicines
    马双成
    WorldJournalofIntegratedTraditionalandWesternMedicine, 2019, 5 (04) : 28 - 31
  • [48] Recent advances in triazoles as tyrosinase inhibitors
    Mermer, Arif
    Demirci, Serpil
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [49] Antiviral compounds from traditional Chinese medicines Galla chinese as inhibitors of HCVNS3 protease
    Duan, DL
    Li, ZQ
    Luo, HP
    Zhang, W
    Chen, LR
    Xu, XJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 6041 - 6044
  • [50] Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design
    Chen, Xiaolan
    Li, Chunqiong
    Wang, Dada
    Chen, Yu
    Zhang, Na
    MOLECULES, 2020, 25 (04):